放射治疗市场、机会、成长动力、产业趋势分析与预测，2024-2032

2023 年全球放射治疗市场价值约为 70 亿美元，预计 2024 年至 2032 年复合年增长率为 5.7%。这种治疗通常使用 X 射线、伽马射线或带电粒子，重点是破坏癌细胞的 DNA，阻碍其生长和分裂。递送方法包括外部机器，如直线加速器（外束放射治疗）或将放射性材料内部放置在靠近癌细胞的地方（近距离放射治疗）。

先进技术，特别是人工智慧（AI）和机器学习的融合，正在提高治疗计划的精确度和个人化程度。影像导引放射治疗 (IGRT) 和调强放射治疗 (IMRT) 等技术可最大限度地减少对健康组织的伤害，从而显着转向精确肿瘤靶向。由于其精确的剂量分布，质子治疗也越来越受到青睐，特别是对于儿科癌症和邻近关键结构的肿瘤。大分割放射治疗可以在较少的疗程中提供更高的剂量，因其成本效益和便利性而进一步受到欢迎。

整个产业分为类型、应用、最终用途和地区。

市场将放射治疗分为体外放射治疗、体内放射治疗和全身放射治疗。外照射段又分为调强放射治疗、影像导引放射治疗、质子治疗等方法。外照射部分引领市场，到 2023 年产生 46 亿美元的收入。

从应用角度来看，市场涵盖肺癌、摄护腺癌、乳癌、子宫颈癌、头颈癌等。到了2023 年，乳癌领域的估值将达到20 亿美元。显着进步。

预测显示，到 2032 年，北美放射治疗市场将达到 41 亿美元，其中美国领先，到 2023 年收入将达到 24 亿美元。加速器，确保患者得到精准且有效率的治疗。此外，公共和私营部门对研发的大量投资正在推动放射治疗技术和设备的创新，最终带来新的疗法和改善的治疗效果。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 放射治疗技术进步
    • 全球癌症病例数不断增加
    • 大众对癌症治疗的认识不断提高
    • 增加医疗基础建设和研发投资
  • 产业陷阱与挑战
    • 发展中和欠发达地区缺乏技术精湛、经验丰富的医疗保健专业人员
• 成长潜力分析
• 未来市场趋势
• 监管环境
• 技术景观
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按类型，2021 - 2032

• 主要趋势
• 外束放射治疗
  • 调强放射治疗 (IMRT)
  • 影像导引放射治疗 (IGRT)
  • 质子治疗
  • 其他外部放射治疗
• 内部放射治疗
• 全身放射治疗

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 肺癌
• 摄护腺癌
• 乳癌
• 子宫颈癌
• 头颈癌
• 其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院
• 放射治疗中心及门诊手术中心
• 癌症研究机构

第 8 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 9 章：公司简介

• Accuray Incorporated
• Brainlab AG
• Curium
• Canon Medical Systems Corporation
• Elekta AB
• Hitachi High-Tech Corporation
• IBA Radiopharma Solutions
• Isoray Inc.
• Mevion Medical Systems
• Mitsubishi Electric Corporation
• Nordion, Inc.
• NTP Radioisotopes SOC Ltd.
• RefleXion
• Toshiba Energy Systems and Solutions Corporation
• Varian Medical Systems, Inc.

The Global Radiotherapy Market was valued at approximately USD 7 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 to 2032. Radiotherapy employs high doses of radiation to eradicate cancer cells and reduce tumor size. The treatment, typically using X-rays, gamma rays, or charged particles, focuses on damaging the DNA of cancer cells, hindering their growth and division. Delivery methods include external machines like linear accelerators (external beam radiotherapy) or internal placement of radioactive materials close to cancer cells (brachytherapy).

Integration of advanced technologies, especially artificial intelligence (AI) and machine learning, is refining the precision and personalization of treatment plans. There is a pronounced shift towards precise tumor targeting, with techniques like image-guided radiotherapy (IGRT) and intensity-modulated radiotherapy (IMRT) minimizing harm to healthy tissues. Proton therapy is also increasingly preferred, particularly for pediatric cancers and tumors adjacent to critical structures, due to its precise dose distribution. Hypofractionated radiotherapy, delivering higher doses over fewer sessions, is further gaining popularity for its cost-effectiveness and convenience.

The overall industry is divided into type, application, end use , and region.

The market categorizes types into external beam radiation therapy, internal radiation therapy, and systemic radiation therapy. The external beam segment further divides into intensity-modulated radiation therapy, image-guided radiation therapy, proton therapy, and other methods. The external beam segment led the market, generating a revenue of USD 4.6 billion in 2023. Advancements in imaging and delivery systems have bolstered the precision and efficacy of external beam radiation therapy (EBRT) for enabling targeted tumor treatment while safeguarding surrounding healthy tissues.

Application-wise, the market covers lung, prostate, breast, cervical, head & neck cancers, among others. The breast cancer segment led with a valuation of USD 2 billion in 2023. Techniques like three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiation therapy (IMRT) have seen significant advancements for enhancing treatment precision, effectiveness, and patient outcomes.

Forecasts suggest that the North American radiotherapy market will hit USD 4.1 billion by 2032, with the U.S. leading at a revenue of USD 2.4 billion in 2023. North America robust healthcare infrastructure supports the adoption of cutting-edge medical technologies, such as proton therapy and advanced linear accelerators, ensuring patients receive precise and efficient treatments. Moreover, substantial investments in research and development from both public and private sectors are driving innovation in radiotherapy techniques and equipment, culminating in novel therapies and improved treatment outcomes.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Technological advancement in radiotherapy
    • 3.2.1.2 Increasing number of cancer cases globally
    • 3.2.1.3 Growing public awareness related to cancer therapy
    • 3.2.1.4 Increasing healthcare infrastructure and R and D investments
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of skilled and experienced healthcare professionals in developing and underdeveloped regions
• 3.3 Growth potential analysis
• 3.4 Future market trends
• 3.5 Regulatory landscape
• 3.6 Technological landscape
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 External beam radiation therapy
  • 5.2.1 Intensity-modulated radiation therapy (IMRT)
  • 5.2.2 Image-guided radiation therapy (IGRT)
  • 5.2.3 Proton therapy
  • 5.2.4 Other external radiation therapies
• 5.3 Internal radiation therapy
• 5.4 Systemic radiation therapy

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Lung cancer
• 6.3 Prostate cancer
• 6.4 Breast cancer
• 6.5 Cervical cancer
• 6.6 Head and neck cancer
• 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Radiotherapy centers and ambulatory surgery centers
• 7.4 Cancer research institutes

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Accuray Incorporated
• 9.2 Brainlab AG
• 9.3 Curium
• 9.4 Canon Medical Systems Corporation
• 9.5 Elekta AB
• 9.6 Hitachi High-Tech Corporation
• 9.7 IBA Radiopharma Solutions
• 9.8 Isoray Inc.
• 9.9 Mevion Medical Systems
• 9.10 Mitsubishi Electric Corporation
• 9.11 Nordion, Inc.
• 9.12 NTP Radioisotopes SOC Ltd.
• 9.13 RefleXion
• 9.14 Toshiba Energy Systems and Solutions Corporation
• 9.15 Varian Medical Systems, Inc.